146 related articles for article (PubMed ID: 17205194)
1. The 22q11.2 deletion syndrome: a gene dosage perspective.
Baldini A
ScientificWorldJournal; 2006 May; 6():1881-7. PubMed ID: 17205194
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis of the Df1 mouse model of the 22q11 deletion syndrome.
Prescott K; Ivins S; Hubank M; Lindsay E; Baldini A; Scambler P
Hum Genet; 2005 May; 116(6):486-96. PubMed ID: 15778864
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic variability of atypical 22q11.2 deletions not including TBX1.
Verhagen JM; Diderich KE; Oudesluijs G; Mancini GM; Eggink AJ; Verkleij-Hagoort AC; Groenenberg IA; Willems PJ; du Plessis FA; de Man SA; Srebniak MI; van Opstal D; Hulsman LO; van Zutven LJ; Wessels MW
Am J Med Genet A; 2012 Oct; 158A(10):2412-20. PubMed ID: 22893440
[TBL] [Abstract][Full Text] [Related]
4. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.
Zweier C; Sticht H; Aydin-Yaylagül I; Campbell CE; Rauch A
Am J Hum Genet; 2007 Mar; 80(3):510-7. PubMed ID: 17273972
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of TBX1 dosage in the anterior heart field results in congenital heart disease resembling the 22q11.2 duplication syndrome.
Hasten E; McDonald-McGinn DM; Crowley TB; Zackai E; Emanuel BS; Morrow BE; Racedo SE
Hum Mol Genet; 2018 Jun; 27(11):1847-1857. PubMed ID: 29509905
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a gene from the DiGeorge chromosomal region homologous to the mouse Tbx1 gene.
Chieffo C; Garvey N; Gong W; Roe B; Zhang G; Silver L; Emanuel BS; Budarf ML
Genomics; 1997 Aug; 43(3):267-77. PubMed ID: 9268629
[TBL] [Abstract][Full Text] [Related]
7. Genetic compensation in a human genomic disorder.
Carelle-Calmels N; Saugier-Veber P; Girard-Lemaire F; Rudolf G; Doray B; Guérin E; Kuhn P; Arrivé M; Gilch C; Schmitt E; Fehrenbach S; Schnebelen A; Frébourg T; Flori E
N Engl J Med; 2009 Mar; 360(12):1211-6. PubMed ID: 19297573
[TBL] [Abstract][Full Text] [Related]
8. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
Prasad SE; Howley S; Murphy KC
Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
[TBL] [Abstract][Full Text] [Related]
9. Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays.
Beaujard MP; Chantot S; Dubois M; Keren B; Carpentier W; Mabboux P; Whalen S; Vodovar M; Siffroi JP; Portnoï MF
Eur J Med Genet; 2009; 52(5):321-7. PubMed ID: 19467348
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility gene card for: DiGeorge syndrome, velocardiofacial syndrome, Shprintzen syndrome, chromosome 22q11.2 deletion syndrome (22q11.2, TBX1).
Schwinger E; Devriendt K; Rauch A; Philip N
Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20125192
[No Abstract] [Full Text] [Related]
11. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
[TBL] [Abstract][Full Text] [Related]
12. Diminished dosage of 22q11 genes disrupts neurogenesis and cortical development in a mouse model of 22q11 deletion/DiGeorge syndrome.
Meechan DW; Tucker ES; Maynard TM; LaMantia AS
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16434-45. PubMed ID: 19805316
[TBL] [Abstract][Full Text] [Related]
13. Developing models of DiGeorge syndrome.
Epstein JA
Trends Genet; 2001 Oct; 17(10):S13-7. PubMed ID: 11585671
[TBL] [Abstract][Full Text] [Related]
14. Genomic findings in patients with clinical suspicion of 22q11.2 deletion syndrome.
Koczkowska M; Wierzba J; Śmigiel R; Sąsiadek M; Cabała M; Ślężak R; Iliszko M; Kardaś I; Limon J; Lipska-Ziętkiewicz BS
J Appl Genet; 2017 Feb; 58(1):93-98. PubMed ID: 27629806
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation.
Stoller JZ; Epstein JA
Hum Mol Genet; 2005 Apr; 14(7):885-92. PubMed ID: 15703190
[TBL] [Abstract][Full Text] [Related]
16. Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.
Guo T; McDonald-McGinn D; Blonska A; Shanske A; Bassett AS; Chow E; Bowser M; Sheridan M; Beemer F; Devriendt K; Swillen A; Breckpot J; Digilio MC; Marino B; Dallapiccola B; Carpenter C; Zheng X; Johnson J; Chung J; Higgins AM; Philip N; Simon TJ; Coleman K; Heine-Suner D; Rosell J; Kates W; Devoto M; Goldmuntz E; Zackai E; Wang T; Shprintzen R; Emanuel B; Morrow B;
Hum Mutat; 2011 Nov; 32(11):1278-89. PubMed ID: 21796729
[TBL] [Abstract][Full Text] [Related]
17. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.
Bassett AS; Marshall CR; Lionel AC; Chow EW; Scherer SW
Hum Mol Genet; 2008 Dec; 17(24):4045-53. PubMed ID: 18806272
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome.
Yamagishi H; Srivastava D
Trends Mol Med; 2003 Sep; 9(9):383-9. PubMed ID: 13129704
[TBL] [Abstract][Full Text] [Related]
19. Typical phenotypic spectrum of velocardiofacial syndrome occurs independently of deletion size in chromosome 22q11.2.
Sandrin-Garcia P; Abramides DV; Martelli LR; Ramos ES; Richieri-Costa A; Passos GA
Mol Cell Biochem; 2007 Sep; 303(1-2):9-17. PubMed ID: 17426930
[TBL] [Abstract][Full Text] [Related]
20. Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome.
Gao S; Li X; Amendt BA
Curr Allergy Asthma Rep; 2013 Dec; 13(6):613-21. PubMed ID: 23996541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
